Cytotoxic CD8

CD8 MACE PAR1 atrial fibrillation atrial myopathy protease-activated receptor t cells thrombin thrombo-inflammation tissue factor

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
29 12 2022
Historique:
received: 25 11 2022
revised: 23 12 2022
accepted: 26 12 2022
entrez: 8 1 2023
pubmed: 9 1 2023
medline: 11 1 2023
Statut: epublish

Résumé

Atrial myopathy and atrial fibrillation (AF) accompany thrombo-inflammation. This facilitates disease progression and promotes major adverse cardiovascular events (MACEs). Thrombin receptor (protease-activated receptor 1, PAR1) signalling is central in mediating thrombo-inflammation. We hypothesised that PAR1 signalling links coagulation and inflammation through cytotoxic CD8 A total of 210 patients were studied. We included data and blood samples from patients presenting with FDAF ( During early AF, a pro-inflammatory and cytotoxic subset of T lymphocytes (CD8 In patients with FDAF, the TF-factor Xa-factor IIa-axis contributes to thrombo-inflammation via PAR1 in CD8

Sections du résumé

BACKGROUND
Atrial myopathy and atrial fibrillation (AF) accompany thrombo-inflammation. This facilitates disease progression and promotes major adverse cardiovascular events (MACEs). Thrombin receptor (protease-activated receptor 1, PAR1) signalling is central in mediating thrombo-inflammation. We hypothesised that PAR1 signalling links coagulation and inflammation through cytotoxic CD8
METHODS
A total of 210 patients were studied. We included data and blood samples from patients presenting with FDAF (
RESULTS
During early AF, a pro-inflammatory and cytotoxic subset of T lymphocytes (CD8
CONCLUSIONS
In patients with FDAF, the TF-factor Xa-factor IIa-axis contributes to thrombo-inflammation via PAR1 in CD8

Identifiants

pubmed: 36611934
pii: cells12010141
doi: 10.3390/cells12010141
pmc: PMC9818535
pii:
doi:

Substances chimiques

Receptor, PAR-1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Cardiovasc Res. 2014 Mar 1;101(3):344-51
pubmed: 24385341
Eur Heart J. 2021 Sep 7;42(34):3227-3337
pubmed: 34458905
Int J Mol Sci. 2019 Jun 08;20(11):
pubmed: 31181772
J Thromb Haemost. 2016 Oct;14(10):1908-1916
pubmed: 27513692
J Immunol Res. 2022 May 12;2022:3647817
pubmed: 35600045
J Atr Fibrillation. 2017 Apr 30;9(6):1530
pubmed: 29250287
Cardiovasc Diabetol. 2020 Feb 17;19(1):20
pubmed: 32066445
Circ Heart Fail. 2015 Jul;8(4):776-87
pubmed: 26022677
Int Heart J. 2012;53(4):221-4
pubmed: 22878798
Cells. 2021 Dec 13;10(12):
pubmed: 34944024
Circulation. 2022 Oct 18;146(16):1196-1206
pubmed: 36030390
Res Pract Thromb Haemost. 2020 Dec 06;5(1):17-26
pubmed: 33537526
Immunology. 2011 Sep;134(1):17-32
pubmed: 21711350
J Immunol. 2011 Oct 15;187(8):4061-7
pubmed: 21918190
J Am Heart Assoc. 2018 Feb 1;7(3):
pubmed: 29419389
Biomolecules. 2021 Aug 07;11(8):
pubmed: 34439833
J Clin Invest. 2013 Mar;123(3):1310-22
pubmed: 23391721
Thromb Haemost. 2017 Jan 26;117(2):349-356
pubmed: 27904907
J Infect Dis. 2013 Feb 15;207(4):638-50
pubmed: 23204166
Eur Heart J Acute Cardiovasc Care. 2022 Nov 2;11(10):772-781
pubmed: 35925661
Thromb Haemost. 2020 Apr;120(4):538-564
pubmed: 32289858
Nat Rev Immunol. 2018 Dec;18(12):733-744
pubmed: 30228378
J Immunol. 2013 Mar 1;190(5):2354-61
pubmed: 23365082
Eur J Pharmacol. 2013 Oct 15;718(1-3):114-23
pubmed: 24041930
Eur Heart J. 2019 Oct 21;40(40):3318-3332
pubmed: 31004144
Sci Rep. 2018 Jun 25;8(1):9624
pubmed: 29941960
J Am Coll Cardiol. 2017 Apr 18;69(15):1990-1992
pubmed: 28408030
Cell Mol Immunol. 2015 Jul;12(4):466-73
pubmed: 25152079
JACC Cardiovasc Imaging. 2020 Aug;13(8):1690-1700
pubmed: 32563642
JCI Insight. 2017 May 4;2(9):
pubmed: 28469072
Thromb Res. 2020 Dec;196:87-98
pubmed: 32853981
Front Cardiovasc Med. 2022 Jul 04;9:879984
pubmed: 35859594
iScience. 2021 Oct 30;24(11):103387
pubmed: 34841225
Inflamm Res. 2021 Dec;70(10-12):1011-1014
pubmed: 34536081
JAMA Intern Med. 2014 Jan;174(1):107-14
pubmed: 24190540
Trends Pharmacol Sci. 2017 Aug;38(8):701-716
pubmed: 28558960
Circ J. 2015;79(11):2329-31
pubmed: 26447121
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Herzschrittmacherther Elektrophysiol. 2018 Mar;29(1):76-83
pubmed: 29234866
Cardiovasc Res. 2021 Jul 27;117(9):2030-2044
pubmed: 32931586
Int J Cardiol. 2019 Jul 15;287:174-180
pubmed: 30527991
J Am Coll Cardiol. 2013 Nov 5;62(19):1737-45
pubmed: 23871888
Biomed Res Int. 2017;2017:3678017
pubmed: 28713823
Cell Mol Life Sci. 2016 Aug;73(16):3009-33
pubmed: 27038487
Thromb Haemost. 2020 Aug;120(8):1182-1187
pubmed: 32594507
Curr Pharm Des. 2016;22(4):472-84
pubmed: 26696253
J Am Coll Cardiol. 2022 Jul 26;80(4):283-295
pubmed: 35863844
JACC Basic Transl Sci. 2016 Jul 13;1(5):328-339
pubmed: 27642643
Lancet. 2022 Apr 9;399(10333):1383-1390
pubmed: 35385695
Eur Heart J. 2020 Oct 1;41(37):3549-3560
pubmed: 33080003
Cells. 2020 Dec 29;10(1):
pubmed: 33383733
Cells. 2021 Sep 30;10(10):
pubmed: 34685585
Cardiovasc Ther. 2014 Jun;32(3):113-9
pubmed: 24533719
Am Heart J. 2020 Jan;219:117-127
pubmed: 31699295
Cardiovasc Diabetol. 2018 Feb 24;17(1):34
pubmed: 29477147
Europace. 2016 Dec;18(suppl 4):iv156-iv162
pubmed: 28011843
Arterioscler Thromb Vasc Biol. 2019 Jan;39(1):13-24
pubmed: 30580574
Circulation. 2022 Sep 13;146(11):836-847
pubmed: 35968706
Arch Med Sci Atheroscler Dis. 2020 Jul 11;5:e140-e147
pubmed: 32832713
J Arrhythm. 2015 Apr;31(2):78-82
pubmed: 26336536
Mol Cells. 2020 May 31;43(5):438-447
pubmed: 32345003
Trends Cardiovasc Med. 2014 Aug;24(6):249-55
pubmed: 25066486
Front Physiol. 2012 Jul 05;3:236
pubmed: 22783202
Math Biosci Eng. 2021 May 27;18(4):4696-4712
pubmed: 34198460
Cell Immunol. 2014 Mar-Apr;288(1-2):47-52
pubmed: 24637088
Cardiovasc Res. 2022 Jul 27;118(10):2367-2384
pubmed: 34352109
Clin Res Cardiol. 2020 Oct;109(10):1271-1281
pubmed: 32072262
Nat Rev Cardiol. 2022 Sep 15;:
pubmed: 36109633
FEBS J. 2021 Apr;288(8):2697-2726
pubmed: 33742547
Sci Rep. 2020 Feb 3;10(1):1685
pubmed: 32015492
Nat Commun. 2021 Mar 5;12(1):1483
pubmed: 33674611
J Card Fail. 2020 Mar;26(3):270-275
pubmed: 31857197
PLoS One. 2015 Apr 17;10(4):e0124716
pubmed: 25884835
Circulation. 2021 Sep 14;144(11):845-858
pubmed: 34328366
Nat Rev Cardiol. 2015 Apr;12(4):230-43
pubmed: 25622848
Clin Res Cardiol. 2021 Jun;110(6):831-840
pubmed: 33098470
Europace. 2016 Oct;18(10):1455-1490
pubmed: 27402624
Eur Heart J. 2017 Jan 1;38(1):53-61
pubmed: 26612579

Auteurs

Julian Friebel (J)

Charité Center 11-Department of Cardiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.
Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany.
Department of Cardiac Anesthesiology and Intensive Care Medicine, German Heart Center, 13353 Berlin, Germany.

Marco Witkowski (M)

Charité Center 11-Department of Cardiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.
Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

Max Wegner (M)

Charité Center 11-Department of Cardiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.

Leon Blöbaum (L)

Charité Center 11-Department of Cardiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.

Stella Lammel (S)

Charité Center 11-Department of Cardiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.

Philipp-Alexander Schencke (PA)

Charité Center 11-Department of Cardiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.

Kai Jakobs (K)

Charité Center 11-Department of Cardiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany.

Marianna Puccini (M)

Charité Center 11-Department of Cardiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.

Daniela Reißner (D)

Charité Center 11-Department of Cardiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.

Daniel Steffens (D)

Charité Center 11-Department of Cardiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.

Verena Moos (V)

Medical Department I, Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.

Heinz-Peter Schutheiss (HP)

Institute for Cardiac Diagnostics and Therapy (IKDT), 12203 Berlin, Germany.

Ulf Landmesser (U)

Charité Center 11-Department of Cardiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.
Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany.

Ursula Rauch (U)

Charité Center 11-Department of Cardiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12203 Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 10785 Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH